| BCBS Kansas | Zynteglo (betibeglogene autotemcel) Medical Drug Criteria Program Summary | 2022-11-15 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Treatment of Malignant Skin Lesions | 2022-11-14 |
| BCBS Highmark NY and West NY | Treatment of Malignant Skin Lesions | 2022-11-14 |
| BCBS Highmark Delaware | Treatment of Malignant Skin Lesions | 2022-11-14 |
| BCBS Highmark West Virginia | Treatment of Malignant Skin Lesions | 2022-11-14 |
| Medicare CGS | Transcutaneous Electrical Nerve Stimulators (TENS) - Policy Article (52520) | 2022-11-11 |
| Medicare Noridian | Transcutaneous Electrical Nerve Stimulators (TENS) - Policy Article (52520) | 2022-11-11 |
| BCBS Kansas | Contrast-Enhanced Coronary Computed Tomography Angiography (CCTA) for Coronary Artery Evaluation | 2022-11-09 |
| Meridian Illinois Medicaid Clinical | Hydroxyprogesterone Caproate (Makena/compound) | 2022-11-03 |
| Meridian Illinois Medicaid Clinical | Tolvaptan (Jynarque, Samsca) | 2022-11-03 |